Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.

While comparisons of the efficacy of TCAD versus dual drug regimens approached but failed to reach statistical significance using mortality as an endpoint in a couple of instances ( Table 1 ), the totality of the data support the conclusion that TCAD is superior to all the double combinations.

also in 6,035 other papers